AMG 162
Showing 1 - 25 of 470
Ovarian Carcinoma Trial in Israel, United States (Denosumab, Salpingo-Oophorectomy)
Terminated
- Ovarian Carcinoma
- Denosumab
- Salpingo-Oophorectomy
-
Boston, Massachusetts
- +5 more
May 23, 2022
Postmenopausal Osteoporosis Treated With Prolia® in France
Completed
- Post Menopausal Osteoporosis
- AMG 162 - Prolia
-
Paris, FranceAmgen
Aug 2, 2021
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Anakinra, Denosumab,
Completed
- Advanced Malignant Neoplasm
- +3 more
- Anakinra
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 24, 2021
Heart Failure, Healthy Volunteer Trial in Worldwide (AMG 986 IV, AMG 986 PO, Placebo PO)
Terminated
- Heart Failure
- Healthy Volunteer
- AMG 986 IV
- +3 more
-
Anaheim, California
- +24 more
Mar 30, 2022
Breast Cancer Trial in Houston (Ra-223 dichloride, Denosumab, Hormone Therapy)
Completed
- Breast Cancer
- Ra-223 dichloride
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 5, 2021
Melanoma Stage Iv, Melanoma Stage Iii, Melanoma Trial in Australia (Denosumab, Nivolumab, Ipilimumab)
Active, not recruiting
- Melanoma Stage Iv
- +2 more
- Denosumab
- +2 more
-
Albury, New South Wales, Australia
- +9 more
Apr 6, 2022
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Locally Advanced Malignant Solid Neoplasm
- Binimetinib
- +22 more
- (no location specified)
Dec 2, 2022
Giant Cell Tumor of Bone Trial in Worldwide (Denosumab (Cohort A))
Active, not recruiting
- Giant Cell Tumor of Bone
- Denosumab (Cohort A)
-
Santa Monica, California
- +13 more
Dec 21, 2021
Metastatic Pancreatic Adenocarcinoma, BRAF Mutated Melanoma Trial in Worldwide (MEK162, AMG 479)
Terminated
- Metastatic Pancreatic Adenocarcinoma
- BRAF Mutated Melanoma
- MEK162
- AMG 479
-
Boston, Massachusetts
- +8 more
Dec 9, 2020
Episodic Migraine Trial in Worldwide (AMG334 (70 mg) Pre-Filled Syringe (PFS), Placebo Pre-Filled Syringe (PFS))
Completed
- Episodic Migraine
- AMG334 (70 mg) Pre-Filled Syringe (PFS)
- Placebo Pre-Filled Syringe (PFS)
-
Heidelberg, Australia
- +58 more
Feb 23, 2022
Breast Cancer Trial in Houston (Denosumab)
Terminated
- Breast Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 5, 2019
Early Stage Breast Cancer Trial in San Francisco (Denosumab)
Terminated
- Early Stage Breast Cancer
-
San Francisco, CaliforniaUniversity of California San Francisco
Dec 13, 2019
Metastatic Osteosarcoma, Recurrent Osteosarcoma, Refractory Osteosarcoma Trial in Canada, Puerto Rico, United States (Denosumab,
Active, not recruiting
- Metastatic Osteosarcoma
- +5 more
- Denosumab
- +2 more
-
Birmingham, Alabama
- +140 more
Apr 27, 2022
Breast Cancer, Low Bone Mineral Density, Osteopenia Trial (Placebo, AMG 162 / Denosumab)
Completed
- Breast Cancer
- +2 more
- Placebo
- AMG 162 / Denosumab
- (no location specified)
Sep 20, 2018
Hypercholesterolemia Trial in Worldwide (biological, drug, other)
Completed
- Hypercholesterolemia
- Evolocumab
- +4 more
-
Birmingham, Alabama
- +95 more
Jul 15, 2022
GCT, Giant Cell Tumor of Bone Trial (Denosumab, Calcium/Vitamin D)
Completed
- GCT
- Giant Cell Tumor of Bone
- Denosumab
- Calcium/Vitamin D
- (no location specified)
Feb 1, 2019
Breast Carcinoma Metastatic in the Bone, Circulating Tumor Cell Count, Estrogen Receptor Positive Trial in Chicago, Lake Forest
Terminated
- Breast Carcinoma Metastatic in the Bone
- +5 more
- Denosumab
- Laboratory Biomarker Analysis
-
Chicago, Illinois
- +1 more
Oct 22, 2018